[New drug approval: Zanubrutinib in monotherapy for chronic lymphocytic leukemia]
- PMID: 37085342
- DOI: 10.1016/j.bulcan.2023.03.020
[New drug approval: Zanubrutinib in monotherapy for chronic lymphocytic leukemia]
Erratum in
-
[Corrigendum to: "Drug approval: Zanubrutinib in monotherapy for chronic lymphocytic leukemia" [Bull Cancer 2023;110:739-745]].Bull Cancer. 2024 Jan;111(1):125. doi: 10.1016/j.bulcan.2023.12.001. Epub 2024 Jan 4. Bull Cancer. 2024. PMID: 38182437 French. No abstract available.
Keywords: BTK inhibitors; Chronic lymphoid leukemia; Inhibiteurs de BTK; Leucémie lymphoïde chronique; Zanubrutinib.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources